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ABSTRACT
Background: This study was aimed to investigate the acute effect of medium-
distance running on bile acids concentration and composition, in order to verify 
whether the positive impact of physical exercise on cancer risk may also be mediated 
by variation of bile acids concentration and composition in serum.
Methods: The concentration and composition of serum bile acids was analyzed 
in 30 middle-aged and healthy recreational athletes with a reference liquid 
chromatography-mass spectrometry technique, immediately before and shortly after 
the end of the running trial. The concentration of bile acids after the run was adjusted 
for plasma volume change.
Results: All athletes successfully completed the trial. After correction of 
values for the individual plasma volume change calculated after the run, the serum 
concentration of total bile acids was found to be significantly reduced by approximately 
46%. A statistically significant decrease was observed for cholic, deoxycholic, 
chenodeoxycholic, ursodeoxycholic, glycoursodeoxycholic and hyodeoxycholic acids, 
whereas the concentration of the remaining compounds remained unvaried after the 
run. A considerable variation of bile acids profile was also observed. No significant 
association was found between running performance and variation of bile acids 
concentrations.
Conclusion: These results show that middle distance running acutely decreases 
the concentration of total bile acids in serum, especially that of the more mutagenic 
and carcinogenic compounds, so providing an intriguing support to the favorable 
effects of physical exercise for lowering the risk of many gastrointestinal cancers.
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INTRODUCTION
Bile acid exposure has been convincingly identified 
as a potential risk factor for many forms of gastrointestinal 
(GI) cancers [1]. In fact, elevated secretion of bile acids is 
associated with an increased incidence of GI cancer [2]. It 
has been reported that high concentrations of secondary 
bile acids damage the GI epithelium as a result of DNA 
oxidative damage, inflammation, and activation of nuclear 
factor-kappa B (NFkB), playing thus an important role in 
GI cancer progression [3].
The bile acids are 24-carbon steroids produced from 
cholesterol in the liver. These compounds are usually 
divided into those directly synthesized by the liver (i.e., 
cholic acid [CA] and chenodeoxycholic acid [CDCA]), 
and those produced by bacterial metabolism of the two 
primary bile acids in the intestine (i.e., deoxycholic acid 
[DCA], lithocholic acid [LCA] and ursodeoxycholic acid 
[UDCA]. Additional metabolic pathways encompass the 
conjugation of CA with glycine or taurine to produce 
taurocholic acid (TCA) and glycocholic acid (GCA), along 
with the conjugation of CDCA with glycine or taurine 
to produce taurochenodeoxycholic acid (TCDCA) and 
glycochenodeoxycholic acid (GCDCA) [4]. Over 90% of 
the plasma or serum concentration of bile acids in humans 
is attributable to DCA, CA and their conjugates (i.e., TCA 
and GCA), as well as to CDCA and its conjugates (i.e., 
TCDCA and GCDCA) [4]. The most important biological 
functions of bile acids encompass the solubilisation of 
dietary lipids, fat-soluble vitamins and other nutrients, 
so that their intestinal adsorption can be substantially 
enhanced [5]. Notably, recent evidence showed that bile 
acids may exert pleotropic functions, such as regulation 
of glucose homeostasis, control of signalling events in the 
liver and overall regulation of energy expenditure [6].
The bile acid levels in faeces and blood may be 
influenced by a number of variables such as total energy 
intake or the amount and type of dietary fats and fibers [7]. 
Besides diet, additional factors may contribute to modify 
the synthesis and concentration of bile acids, so possibly 
including physical exercise. The potential interplay between 
physical activity and cancer is not insignificant, wherein the 
former exerts a variety of favorable health effects, including 
protective action against certain types of cancer [8]. In this 
regard, it has been reported that regular physical activity 
provides protection against GI cancer risk [9], although the 
mechanisms implicated remain to be understood.
Therefore, we designed this study to investigate the 
acute effect of medium-distance running (i.e., 21.1 km) on 
bile acids concentration and composition in the serum of 
30 middle-aged and healthy recreational athletes, in order 
to verify whether the positive impact of exercise on GI 
cancer risk may also be mediated by a variation of bile 
acids concentration and composition in serum.
RESULTS
The baseline concentration of hemoglobin, 
hematocrit and bile acids is shown in Table 1 . The total 
concentration of bile acids pre-exercise was 3.20 μmol/L. 
GCDCA was the most represented bile acid, followed 
by CDCA, DCA, GDCA, GCA and CA. In agreement 
with published data [4], these 6 bile acids represented 
altogether 86% of the total concentration of bile acids in 
serum.
All athletes successfully completed the 21.1 km 
trial, with a mean time of 1h52min42sec (range between 
1h31min00sec and 2h31min11sec). The mean variation 
of hemoglobin, hematocrit and bile acids after the trial 
is shown in Table 1 . No significant variation of both 
hemoglobin and hematocrit values could be detected 
after-exercise (Table 1), so that the plasma volume change 
was also insignificant (-1%; IQR, -4% to 4%). This is in 
agreement with the observation that the body weight did 
not significantly vary before and after the trial (p=0.308). 
After correction for individual plasma volume change, the 
concentration of total bile acids in serum was found to be 
significantly reduced, by approximately 46% (IQR, 15-
60%), and a decreased concentration was observed in 23 out 
of 30 athletes (77%; p=0.030). As regards the specific bile 
acids, a statistically significant decrease was recorded for 
CA, DCA, CDCA, UDCA, GUDCA and HDCA, whereas 
the serum concentration of the remaining compounds 
was mostly unaffected. A trend toward increased values 
was noticed for TCDCA, though only approximating 
statistical significance. Interestingly, the number of athletes 
displaying a significant decrease of serum concentration of 
the single bile acid reached statistical significance for CA, 
DCA, CDCA, UDCA and HDCA.
The variation of bile acids profile as percent of total 
bile acids is shown in Figure 1. A significant reduction 
of the percent value was hence observed for CA, DCA, 
CDCA and UDCA, a significant increase of percent 
values was observed for TCDCA, GDCA, GCDCA and 
TCA, whereas the percent value remained unvaried for 
GCA, GUDCA, HDCA and LCA. The number of athletes 
displaying a significant decrease of percent value reached 
statistical significance for CA, DCA, CDCA and UDCA, 
whereas a significant increase of percent value reached 
statistical significance for TCDCA and TCA (Table 2).
As predictable, a significant correlation was 
observed between running time and sex, whereas no 
significant associations were found between running 
performance and variation of bile acids concentrations, 
expressed as the ratio between pre- and post-exercise 
serum values. The associations between running time 
and variation of bile acids concentrations after the run 
remained non-significant also after including sex as a 
covariate in the correlation analysis
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DISCUSSION
Controversial information has been provided 
about the relationship between physical exercise and 
bile acids metabolism, mostly based on a limited number 
of cross-sectional studies. Sutherland et al carried out a 
small cross-sectional study including 14 male distance 
runners and 14 sedentary men [10]. In agreement with our 
findings in serum, the total fecal bile acid concentration 
was found to be significantly lower in athletes compared 
to the control population of sedentary men. Wertheim et 
al carried out a larger cross-sectional analysis of baseline 
fecal bile acid concentration in 735 participants of a 
phase III ursodeoxycholic acid chemoprevention trial 
[11]. Subjects in the highest quartile of adjusted hours per 
day of recreational activity displayed a 17% lower total 
fecal bile acid concentration compared to subjects in the 
lowest quartile, after adjustment for age, sex and body 
mass index. Opposite findings were instead reported in a 
subsequent study. Briefly, Prinz et al studied 43 female 
anorexic with broad activity patterns, and found that the 
total concentration of plasma bile acids was not associated 
with either metabolic equivalents/day (r=0.162; p=0.304) 
or total energy expenditure (r=0.147; p=0.352) [12]. This 
difference has been explained with the fact that bile acids 
in plasma were negatively correlated with the cognitive 
restraint of eating, so that their metabolism undergoes a 
compensatory adaptation to prevent further overeating 
after exercising.
Taken together, the results of our study demonstrate for 
the first time that exercise (but not the individual performance 
expressed as running time) acutely influences both the 
concentration and composition of bile acids in the blood of 
recreational athletes. Interestingly, middle-distance running 
was effective to acutely decrease the total concentration of 
serum bile acids, as well as the relative serum values of CA, 
DCA, CDCA, UDCA, GUDCA and HDCA, whereas the 
serum concentration of the remaining bile acids was mostly 
unaffected (Table 1). The composition of serum bile acids 
was also found to be substantially modified immediately 
after the run, since the relative contribution of some bile acids 
to the total amount was decreased (i.e., CA, DCA, CDCA 
and UDCA), whereas the relative contribution of other 
compounds was found to be increased (i.e., TCDCA, GDCA, 
GCDCA and TCA) (Figure 1).
These findings may have important implications 
for GI cancer biology. It has been clearly established 
that bile acids play an essential role in carcinogenesis, 
Table 1. Variation of bile acids after a 21 km, half-marathon run
Variable Pre-exercise Post- exercise p
Body weight (kg) 73.7 (64.7-80.6) 73.6 (64.9-80.3) 0.308
Plasma volume change (%) - -1% (-4 to 4%) -
Hemoglobin (g/L) 148 (139-153) 148 (137-154) 0.416
Hematocrit 0.45 (0.44-0.47) 0.45 (0.43-0.47) 0.332
Bile acids
- CA (μmol/L) 0.16 (0.06-0.77) 0.06 (0.02-0.13) 0.004
- DCA (μmol/L) 0.32 (0.18-0.64) 0.10 (0.06-0.17) <0.001
- CDCA (μmol/L) 0.39 (0.11-0.88) 0.12 (0.06-0.24) 0.001
- UDCA (μmol/L) 0.05 (0.01-0.15) 0.01 (0.00-0.02) <0.001
- TCDCA (μmol/L) 0.09 (0.05-0.23) 0.14 (0.07-0.31) 0.068
- GCA (μmol/L) 0.20 (0.13-0.46) 0.15 (0.06-0.32) 0.397
- GDCA (μmol/L) 0.22 (0.16-0.29) 0.17 (0.10-0.33) 0.237
- GUDCA (μmol/L) 0.06 (0.04-0.08) 0.06 (0.04-0.06) 0.033
- GCDCA (μmol/L) 0.71 (0.51-1.39) 0.71 (0.47-1.15) 0.463
- HDCA (μmol/L) 0.14 (0.07-0.23) 0.07 (0.04-0.15) 0.003
- LCA (μmol/L) 0.01 (0.01-0.02) 0.01 (0.01-0.02) 0.132
- TCA (μmol/L) 0.02 (0.01-0.05) 0.02 (0.01-0.05) 0.189
- Total bile acids (μmol/L) 3.20 (1.76-6.16) 2.02 (1.20-3.10) 0.016
Results are shown as median and interquartile range (IQR).
CA, cholic acid; DCA, deoxycholic acid; CDCA, chenodeoxycholic acid; UDCA, ursodeoxycholic acid; TCDCA, 
taurochenodeoxycholic acid; GA, glycocholic acid; GCDCA, glycochenodeoxycholic acid; GUDCA, glycoursodeoxycholic 
acid; HDCA, hyodeoxycholic acid; GDCA, glycodeoxycholic acid; LCA, lithocholic acid; TCA, taurocholic acid.
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as supported by reliable epidemiological and biological 
evidence [13–16]. In particular, many studies found that 
an increased concentration of bile acids in both faeces and 
serum is strongly associated with the risk of developing 
many GI cancers, including cholangiocarcinoma, 
colorectal, pancreatic and gastric malignancies [1] [13–
15]. The observation that also the serum concentration 
of these compounds may be associated with the risk of 
GI cancers is reasonable, since bile acids formed in the 
colon are then absorbed into the portal venous blood and 
then constantly released into systemic circulation [16]. 
Notably, the measurement of bile acids in serum or plasma 
has also some advantages over their assessment in stool. 
The biological matrix (i.e., the serum) can be obtained 
much more easily than the faeces, the measurements are 
more reliable and standardized, and recent dietary intake 
has a less important effect on bile concentration and 
composition of bile acids in serum than in stool.
As regards the biological link between bile acids 
and carcinogenesis, this association is supported by a 
variety of pro-carcinogenic effects that bile acids may 
exert, so including generation of reactive oxygen and 
nitrogen species, cell membrane perturbation, direct DNA 
damage, disruption of mitochondria, promotion of cell 
proliferation and mitotic events, reduced susceptibility 
to apoptosis, as well as activation of erbB2 and EGFR 
signaling cascades [13]. Therefore, our finding that the 
release of bile acids into the circulation is acutely reduced 
by approximately 46% immediately after exercise may 
bring an additional and reasonable explanation to the 
favorable impact of physical exercise for lowering the 
risk of GI cancers. Notably, some bile acids compounds 
(especially non-conjugated bile acids and DCA) were 
found to exert stronger pro-carcinogenic effects than 
others [17]. Accordingly, our observed decrease in the 
concentrations of serum CA (median reduction, 88%; 
IQR, 51-88%), CDCA (median reduction, 75%; IQR; 
51-84%) and DCA (median reduction, 67%; IQR, 53-
76%) after the run further reinforces this hypothesis. As 
regards the potential mechanisms linking exercise and 
variation of bile acids metabolism, it is well-established 
that endurance exercise acutely lowers serum cholesterol 
concentration, a finding that has also been previously 
confirmed in middle-distance runners [18]. The lower 
Figure 1: Composition of bile acids profile in serum immediately before (“pre”) and shortly after (“post”) middle 
distance running in 30 adult recreational athletes. CA, cholic acid; DCA, deoxycholic acid; CDCA, chenodeoxycholic acid; UDCA, 
ursodeoxycholic acid; TCDCA, taurochenodeoxycholic acid; GA, glycocholic acid; GCDCA, glycochenodeoxycholic acid; GUDCA, 
glycoursodeoxycholic acid; HDCA, hyodeoxycholic acid; GDCA, glycodeoxycholic acid; LCA, lithocholic acid; TCA, taurocholic acid.
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availability of cholesterol in blood during endurance 
exercise would hence represent a limiting step for the 
efficient synthesis of primary bile acids in the liver. As 
regards the relative variations of the different bile acids in 
serum, the substantial decrease of CA, DCA, CDCA and 
UDCA attests that the primary release into blood of non-
conjugated bile acids and their main intestinal derivatives 
may be strongly impaired during exercise (Table 1), so 
contributing to decrease their relative contribution to the 
total serum pool of bile acids after the run (Figure 1). 
Conversely, the serum concentration of TCDCA, GDCA, 
GCDCA and TCA (i.e., products of conjugation of CDCA 
or CA with glycine or taurine) remained unchanged after 
distance running (Table 1), so explaining their increased 
contribution to the total serum pool of bile acids after the 
trial (Figure 1). Besides TCDCA, also GCDCA (the other 
product of CDCA conjugation) displayed a relatively 
increased value compared to the other bile acids, closely 
approaching statistical significance (Table 2). These two 
bile acids are those characterized by the higher bile acids 
uptake rate by human bile salt export pump (1400 pmol/
mg per 30 s for TCDCA and 1000 pmol/mg per 30 s for 
GCDCA, respectively), which plays an important role in 
the clearance of bile acids [19]. Since the liver is subjected 
to exercise-induced cellular stress during prolonged 
exercise, it is hence conceivable that transitory hepatocyte 
sufferance may lead to a greater release of these two 
compounds into the circulation, so explaining the relative 
increase of their measurable values in plasma compared to 
the other bile acids.
In conclusion, our results confirm reliable evidence 
that exercise, particularly aerobic or endurance exercise 
(i.e., middle distance running), may acutely decrease the 
concentration of total bile acids, especially that of the more 
mutagenic and carcinogenic compounds. We provide thus 
an additional and putative explanation to the favorable 
effects exerted by physical exercise for lowering the risk of 
many GI cancers in which bile acids my act as promoters 
and/or contributors [20]. Unfortunately, we could not 
measure plasma bile acids at different time points after 
the run. Therefore, it remains to be established whether 
carcinogenesis can be abated by abruptly decreasing the 
concentrations of bile salts after endurance running and 
active lifestyle characterized by a lower volume of exercise 
would equally effective in reducing carcinogenesis.
MATERIALS AND METHODS
This study was part of the “Run For Science,” 
a special event hold in Verona (Italy) in April 2014, 
and designed to study the physiological response of 
recreational athletes to half-marathon running (the 
full information of the event can be retrieved from the 
Verona University Website, at: http://www.dsnm.univr.
Table 2: Number of subjects with post-exercise decrease of bile acids concentration
Bile acids Athletes with decrease of absolute serum concentration p
Athletes with decrease of 
percent value over total bile 
acids concentration
p
CA 26/30 (87%) 0.003 24/30 (80%) 0.015
DCA 28/30 (93%) <0.001 25/30 (83%) 0.007
CDCA 26/30 (87%) 0.003 25/30 (83%) 0.007
UDCA 28/30 (93%) <0.001 25/30 (83%) 0.007
TCDCA 16/30 (53%) 0.398 1/30 (3%) <0.001
GCA 20/30 (67%) 0.145 15/30 (50%) 0.500
GDCA 18/30 (60%) 0.302 9/30 (30%) 0.094
GUDCA 20/30 (67%) 0.145 12/30 (40%) 0.302
GCDCA 16/30 (53%) 0.398 8/30 (27%) 0.056
HDCA 25/30 (83%) 0.007 16/30 (53%) 0.398
LCA 19/30 (63%) 0.217 11/30 (37%) 0.217
TCA 13/30 (43%) 0.398 3/30 (10%) 0.001
Total bile acids 23/30 (77%) 0.030 -
CA, cholic acid; DCA, deoxycholic acid; CDCA, chenodeoxycholic acid; UDCA, ursodeoxycholic acid; TCDCA, 
taurochenodeoxycholic acid; GA, glycocholic acid; GCDCA, glycochenodeoxycholic acid; GUDCA, glycoursodeoxycholic 
acid; HDCA, hyodeoxycholic acid; GDCA, glycodeoxycholic acid; LCA, lithocholic acid; TCA, taurocholic acid.
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it/?ent=iniziativa&id=5382, Last accessed, 12 February 
2017). Specifically, 30 amateur runners (9 women and 
21 men; mean age: 45 years, range 31-62 years; mean 
body mass index: 23.4, range: 19.8-27.9) successfully 
performed a 21.1 km (half-marathon) run. All athletes 
were part of an amateur running team, regularly engaged 
in recreational running (median training regimen, 219 min/
week). The participants were asked to cease all exercise 
training and abstain from taking drugs or medications 
48 hours before the event. No subject was regularly 
taking fibrates, bile acid sequestrants, niacin or statins. A 
control population was not included in this study since, 
as previously shown by Zheng et al, up to 2-4 hours 
fasting does not generate a significant variation of total 
bile acids values and bile acids composition in serum [21]. 
Therefore, all the changes potentially observed are almost 
entirely attributable to the effect of distance running.
The event developed as follows. The start was 
given at 9.30 AM and the full running distance (21.1 km) 
developed on a relatively flat route, located at 5 km from 
the town of Verona (35 m vertical gain, maximal slope of 
1.8%). The weather conditions were optimal, i.e., partially 
sunny day with temperatures comprised between 12-19° 
C and humidity ranging between 55-75%. All participants 
run with a heart rate monitor (HRM) and were allowed to 
drink ad libitum during the run, but were asked to abstain 
from intaking food or caloric beverages, which were only 
allowed at the conclusion of the trial after blood sampling. 
Two blood collections were performed, the former just 
before the start of the run and the latter immediately after 
crossing the finishing line. The blood was collected in 
two primary blood tubes, the former without additives 
and the latter containing K2EDTA (Terumo Europe 
N.V., Leuven, Belgium). All samples were immediately 
conveyed by car and using a refrigerated transport box to 
the laboratory of clinical biochemistry and hematology 
of the University Hospital of Verona. Immediately after 
arrival to the laboratory, the blood tubes without additives 
were centrifuged for 10 min at 1300 x g, the serum was 
separated and then stored in aliquots at -70°C. A full blood 
count was instead immediately performed on K2EDTA 
blood tubes, using an ADVIA 2120 (Siemens Healthcare 
Diagnostics, Tarrytown, NY, USA).
The measurement of bile acids was performed as 
follows. A pre-exercise and post-exercise serum aliquot of 
each athlete was thawed at room temperature for 3 hours. 
The serum in the aliquots was mixed by 10-time gentle 
inversion and then measured with liquid chromatography-
mass spectrometry (LC-MS). Separate measurements were 
performed in order to detect and quantify a panel of bile 
acids covering at least 99% of total bile acids contents in 
serum or plasma [21]: CA, DCA, CDCA, UDCA, TCDCA, 
GCA, GCDCA, glycoursodeoxycholic acid (GUDCA), 
hyodeoxycholic acid (HDCA), glycodeoxycholic acid 
(GDCA), LCA and TCA. Briefly, three deuterated internal 
standards (IS) were used for quantification: cholic-
2,2,4,4-d4 Acid (CA-d4), chenodeoxycholic -2,2,4,4-
d4 acid (CDCA-d4) and deoxycholic-2,2,4,4-d4 acid 
(DCA-d4). All reagents, so including UHPLC-grade 
ammonium formate, methanol and acetonitrile were 
obtained from Sigma Aldrich (St. Louis, MO, USA) or 
Santa Cruz (CA, USA). The separation was performed 
with a Nexera X2 series UHPLC (Shimadzu, Kyoto, 
Japan) equipped with a Phenomenex Kinetex C18 (500 x 
2.1 mm, 2.6 μm) column. The temperature of the column 
was set at 50°C. The mobile phase A and B were 5 mM 
aqueous ammonium formate and acetonitrile and methanol 
(50:50), respectively. A gradient elution under 0.5 mL/min 
flow rate was carried out entailing 30% B for 0.3 min, 
linear increase to 90% B up to 5 min, followed by 90% B 
between 5-7 min and re-equilibration between 7-12 min 
with 30% B. The chromatographic system was coupled 
with a 4500 MD triple quadrupole MS detector (ABSciex, 
Darmstadt, Germany). The electrospray ionization was 
completed in negative mode, as follows: 30 psi (curtain 
gas), 550°C (Source Temperature) -3500 V (Ion Spray 
Voltage), 45 psi/55 psi (Ion Gas 1 and 2, respectively). 
Data were then recorded in multiple reaction monitoring 
mode (MRM), using nitrogen as collision gas. System 
operation, data acquisition and quantification were based 
on Analyst 1.6.2. software (AB Sciex) and Multiquant 
3.0.2. (AB Sciex). The declustering potential, collision cell 
parameters and transitions were all optimized according to 
the various bile acids under to be measured.
A mixed stock solution of each bile acid standard 
was prepared in methanol and then diluted with 
methanol:water (50:50, v:v) to prepare a 6-point curve 
of calibration. The sample preparation was carried out 
in accord with published methods [22] [23] and minor 
modifications. Briefly, 500 μL of serum was spiked with 
5μL of IS-mixture (24 μmol/L D4-CA, 25μmol/L D4-
DCA, 25 μmol/L D4-CDCA), mixed with 1000 μL of 
acetonitrile and then vortexed for 1 min. After 15 min of 
centrifugation at 13000 x g, 500 μL of the supernatant 
were transferred to autosampler vials for UHPL-MS 
analysis. The injection volume was 2 μL. The limit of 
quantitation (LOQ), determined as a signal-to-noise ratio 
of ten, was below 20 nmol/L for all bile acid compounds. 
The intra-assay imprecision was comprised between 1.2-
2.4%, whereas the inter-assay imprecision was comprised 
between 4.4-6.4%. The total concentration of bile acids 
in serum was obtained as the sum of data obtained from 
single measurement of each of the 12 bile acids. The 
statistical analysis was performed after correcting the 
absolute serum values of the single bile acids, as well as 
the total bile acid concentration, for the observed variation 
of plasma volume after exercise, using the validated 
formula of Dill and Costill [24].
Since the values of all variables did not follow a 
normal distribution, as established by Kolmogorov–
Smirnov test, results were shown as median and 
interquartile range (IQR). The statistical analysis was also 
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based on non-parametric tests, entailing Wilcoxon test 
for paired samples, chi square test with Yates’ correction 
and Pearson’s correlation, using Analyse-it (Analyse-it 
Software Ltd, Leeds, UK).
All subjects enrolled in this study provided a 
written consent. Likewise, this study was approved by 
the local ethical committee (Department of Neurological, 
Neuropsychological, Morphological and Movement 
Sciences, University of Verona, Italy) and was carried out 
in accordance with the Helsinki Declaration.
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